Anthropic IPO roadshow - CEO Dario Amodei in Conversation with Jamie Dimon

Jamie Dimon
17 followers
1 Video View·Nov 17, 2026
Anthropic CEO Dario Amodei in Conversation with Jamie Dimon,IPO roadshow,路演
AI Generated·May contain errors
Video Summary
AI GeneratedDario Amodei, CEO of Anthropic, discusses the company's trajectory, focusing on its unique culture, the enterprise application of Claude AI, and the critical balance between innovation and safety. The conversation covers strategic compute management, the potential for AI-driven scientific breakthroughs, and the company's commitment to public benefit through its upcoming IPO.
Please welcome to the stage, Mary Erdos,
CEO of Asset and Wealth Management.
Welcome, everybody. I'm Mary Erdos.
I'm responsible for most of the investors across JPMorgan Chase.
And on behalf of all of my partners, Jamie, and everyone in the room,
thank you so much for joining us in what is likely
to be the most consequential IPO of all times.
And we are so thrilled that each
and every one of you are here for this.
We are really, really looking forward to this conversation.
We have spent a lot of time figuring out how to pull this together.
We have so many, I'm looking at the front row here,
so many of the earliest investors within the fund, within the company.
We have so many people that have flown in from around the world.
We have people from Egypt.
We have people from Turkey.
We even have people from your hometown.
In Italy, your family's hometown, so we're really excited about that.
But most importantly, as you know,
JPMorgan Chase has 5,500 branches across this country.
We have 62 other countries that are dialed in,
and of course, countless other people
that are streaming here.
And so we couldn't be more excited about today.
I remember...
Three years ago, almost to the day,
sitting in Dr. Kissinger's office with Eric Schmidt,
and Dr. Kissinger had just met with Dario,
and he said to me, in that office, he said,
we are entering a new period of human consciousness,
and it will be the equivalent of the enlightenment.
And Eric Schmidt said, after that, we will be talking about
this period of time for thousands of years to come.
And that's why it's so exciting for all of us to be here today.
And before we get started,
I just wanted to make a quick shout out to a person that many
of you know in the room, but Krishna, could you just stand up?
CFO extraordinaire, the person who is helping us to get through things.
I called Philippe and asked him for a quote on you.
You want it?
I'll give it to you.
He's probably said it to you before.
He said, he's extraordinary at building trust.
He simplifies complexity.
But he is an excellent steward of capital.
And then this morning, somebody who you were an alumni of,
John Gray, said to me,
he is a world-class financial executive and leader,
but he's even better human being.
And that's probably the most meaningful thing of all.
Now we are going to introduce the master, Dario.
Who really needs no introduction, a physicist by training.
His thesis professor, when he won the Hertz Award, said,
you were the smartest PhD ever at Princeton University.
He believes that you have
been a leading human being across all of this.
And when Ashton Kutcher talked about you
in the Time Person of the Year,
he said there are three things that drive
this man to be the person that he is.
One, his physics background, which gives him his analytical expertise.
Two, his neuroscience background,
which allows him to help us to understand the intelligence layer.
But most of all, he is kind,
and that's actually the kind of person we need,
driving what we are doing here today.
And so, I believe we are about to see the leadership...
of Dario and his amazing management team lead us
to the largest IPO in history.
And for that, Jamie Dimon is going to lead us in conversation,
introducing the two people that don't need
their last names, Dario and Jamie.
Mary, thank you very much.
Dario Amodei is here, his wife.
So welcome.
Welcome, everybody.
I'm looking at the faces.
I haven't seen a bunch of you for a while.
I wish I saw more of you a little bit.
I hope you enjoy this building and upstairs
and some of the food afterwards.
This company, and Mary, thank you very much.
I mean, the effort you make for your clients and this company
and our country in some cases is extraordinary.
So thank you to all the JPMorgan Chase people in the room.
Dario, welcome.
You started this company in the year 2020, but I just want to go back.
I first saw AI because we hired Palantir to help us in 2012.
And once we saw, we started our own AI department,
and we now have 1,000 people doing it,
aided and abetted by Anthropic, 1,000 use cases.
I always remind people, we are going to use AI
to do a better job for our clients.
That's it.
And as best as we can, it's still at the tip of the iceberg.
So I do have some questions.
I want to make sure I ask the right ones from you, Dario.
You worked at OpenAI, but you were a pioneer in this field,
and obviously now a lot of companies doing AI.
So how have you been able to differentiate
from the other ones around the world?
So first of all, I just wanted to say thank you for inviting me here.
Thank you everyone for coming. Thank you, Mary, for the intro.
Yeah, there's obviously a lot of people building AI technology.
I've worked at most of the major companies in the space,
And as I've thought about my time working with various people
and what has made projects succeed
and what has made projects not succeed,
the conclusion I've drawn after many years
and after working at many places
is that talent and culture are the most important things.
That it is the talent and the culture that generate the technology.
It's the technology that generates the products.
And it's the, you know, the products that generate the go to market
and the sales and everything else that the company does,
and that the company's, the company's presence, how the public sees it
also comes from the talent and the intentions of the people
who build the technology. So when we set out to start Anthropic,
when we left the place that we were before, the thing that that
You know, from day one,
myself and the other six co-founders said, you know,
we're going to focus on talent and we're going to focus on culture.
And right from the beginning, we set things up in that way.
We have a culture interview that everyone goes through,
and we've been very disciplined about turning down people
who are deeply technically talented.
But who don't fit our culture, right?
We don't want people who are jerks.
We don't want people who try to steal the show
and don't work well with others.
We don't want people who aren't oriented
towards the public benefit.
And it turns out if you stick to that consistently,
it's painful in the short run,
but you get a team where everyone works together
and everyone is on the same side.
One of the things that most causes difficulty for companies
is if you have an incredible team, but people aren't working together.
They're working against each other.
You have this team that works against that team,
that works against the third team,
and they spend all of their energy fighting each other.
Whereas at Anthropic,
what we found is that everyone is able to work together.
When there's an important goal,
whether it's training a model, or achieving a safety objective,
or building the right product, or making something happen in policy,
The whole company comes together to make it happen.
And we see it, we see it in the results.
Many more people come to Anthropic
from other companies than leave Anthropic.
We have the best retention rates in the industry.
All seven co-founders of the company are still present.
That's something that's not true
of most of the other players.
Of the original 100 employees to join,
more than three quarters are still at Anthropic.
It's relatively frequent that even those
who leave Anthropic often come back.
You know, one time we had two major product people
leave and they came back right right within two weeks,
you know, they said sorry we didn't appreciate what we had
So every every, you know, I I paid probably 40 50 percent
of my time focused on talent and culture
And, you know, every two weeks I get up in front of the company.
We have something called DVQ, Dario Vision Quest.
It's kind of a goofy name.
But the idea is that I speak honestly to everyone at the company.
I tell them what's going on.
I don't try to hide things.
I don't speak in corpo speak.
And I encourage the other leaders to emulate that.
And so it means that the leaders
of the company can trust the employees.
The employees of the company can trust
the leaders of the company to be candid.
Everyone feels that we're being honest with them,
and that has this enormous value.
Thank you very much for that.
We're one of your largest customers.
It's been transformational for us.
We have 250,000 employees that use it many times
a week in various different forms, by the way.
All right.
How are the other Fortune 100 companies leveraging Claude?
Yeah, so, you know, we apply Claude across all kinds of industries.
I think one of the most incredible things about
this technology is its generality.
We have what you might call a Moore's Law for cognition
or a Moore's Law for intelligence.
And so one of the amazing opportunities
is that I've gotten to learn a lot about industries
that I didn't know anything about,
as well as apply Claude to industries that I know
a lot about or that I used
to be in and see what incredible things can happen.
This ranges from, you know, certainly coding, that was the area
that was the earliest and the fastest adoption within enterprises.
You know, of course, I used to write a lot of code myself,
so did most of my co-founders,
and it's incredible to see what the models are able to do.
And, you know, of course,
every company within the Fortune 100 has an incredible need for coding.
That's usually where the first adoption is.
We then go to things like knowledge work more broadly.
So within financial services,
we see Claude used from the simplest paperwork
to the most complicated strategies
within areas like insurance, legal.
Claude's great at drafting contracts,
finding flaws in contracts.
Life sciences is one I'm very excited about.
We'll probably get to that more later.
But everything from.
Drafting clinical study reports to helping
with the fundamental research, you know, predicting protein binding,
helping make manufacturing more efficient,
making fundamental biological discoveries.
Similarly, we've seen things in, you know,
things like e-commerce where Claude is more efficient.
Some folks will deploy.
Claude as customer-facing agents.
So there's really an incredible range, right?
Industries like manufacturing
that I didn't know anything about,
I'm starting to learn about
because I talk to the manufacturing CEOs
and they're increasingly starting to use Claude
to make their business more efficient.
Covers also areas like semiconductor manufacturing,
physical construction, so really across the board.
You raised the question of agents,
which of course is news today for everybody using agents.
All right.
So if you need to be trusted in a company,
you're regulated, what do you think people
have to do before they actually point agents
at their sensitive information?
Yeah, so, you know, I think the number one thing is actually safety.
These agents are getting incredibly capable, incredibly quickly.
The difficulty is not whether an agent can do this incredibly
difficult task in life sciences or writing software architecture.
The pace at which they're progressing is incredible.
The thing that actually limits us in our development of the technology,
limits us in our internal deployment,
and also limits customers is doing it safely.
We don't want these agents to run wild,
and that's why Anthropic has invested, I think, more than any
other company in the space in building this technology safely,
in making sure that we have the right safeguards that run from,
you know, when we originally trained the model,
making sure we get safety and alignment right.
You know, we have a very large alignment team.
We're very paranoid. Every few months, we say,
we put all this effort into safety and security alignment.
And we need to do another sprint to put even more effort into safety
and safety and security and alignment.
From the beginning, Anthropic has been a company
that's been focused on enterprises.
And we know that enterprises care about this more so than consumers do.
We sort of deliberately chose enterprise as a focus because we
understood that it was synergistic with our focus on safety, right?
We care about safety for values reasons.
We thought about that at the beginning when we started the company.
Safety is what matters.
We want to get this right.
We want to build this technology in the right way.
And then we said to ourselves, what is the focus?
What is the business focus that will give us
the right incentives to pursue safety?
And that turned out to be enterprise,
because enterprises care about trust.
They care about long-term relationships.
And they care about preserving their reputation
and making sure that models don't recap it.
And so it's been very helpful to us as an incentive,
as a pro-social incentive in aligning our own business incentives
with what we ultimately want to accomplish in society,
which is building this technology in a way that's good for society.
Are we going to be able to control the agents, like limit what they can
do to actually allow them in sensitive systems,
but know for a fact they can only do A, B, C, and D and not?
Yeah, so, you know, one thing I would compare it to is,
you know, it's a little bit like, you know,
something like the evolution of cars that drive themselves, right?
You know, this is an incredible technology
that has incredible benefits.
It's, in the end, going to be much safer than humans doing
the same things, right?
You know, humans driving cars are actually quite dangerous.
AI systems driving cars can be ten times or a hundred times more safe,
but you have to get them across that line, right?
And you have to make sure you have the right safeguards,
you build them in the right way.
You're never going to have a 100% guarantee, right?
You're never going to be able to say,
this self-driving car,
no matter how many billions of people I deploy it to,
it will never once crash.
That's just the world doesn't work like that.
But what I think we will be able to get to is this is much,
much safer, many times safer,
a hundred, a thousand times safer than
if you had humans operate the car.
And I think that's what we're aiming for.
When we moved to compute,
you guys disclosed that you have $900 billion of forward commitments
for compute leases and data centers, et cetera.
And I read somewhere that 80% of compute is doing new models,
and something like only 20% is inference, which most of us actually do.
So how do you know you're going to get what you need
and make it very cost-efficient down the road?
Yeah, so I would say compute is the deepest business dilemma that...
that the company faces so the issue that we have
with compute is that because this field is growing
so fast from a technological perspective
and we don't know how that is going to transfer
to the creation of economic value
on the business side we have this huge uncertainty
in 2024 and 2025 in both of those years
the company's revenue grew by roughly 10x
And every year we look at it and we say,
we don't know what's going to happen next year.
There's a huge uncertainty in what's going to happen next year.
And, you know, deepening the dilemma,
every year the numbers are larger.
At the same time, we have to buy compute a year
or two years ahead of time.
And the compute depends on how much the company can afford to pay for.
If you buy too much, of course,
you can financially overextend yourself.
If you buy too little, then you can't support inference for customers.
And even more importantly,
as Jamie is hinting at, you can't do the R&D,
which is what produces the model six or 12 months from now,
which is what determines your ability
to generate revenue in the future.
So it's a very difficult problem.
Now, there are two ways we soften it.
And...
One way that, you know, strategy that we take for investing it.
The two ways to soften it are, one, the better your gross margins are,
the bigger the buffer between too much and too little, right?
The gross margin is basically the difference
between how much you pay for the compute
and how much, you know, how much money you make per unit of compute.
And so, you know, as you can see in the S-1,
our gross margins are quite good,
especially compared to other players in the space.
The second form of buffer.
is cash on the balance sheet, and we have an enormous, you know,
as you've seen, we have an enormous amount of cash on the balance sheet
and seeking to get more, but even with that,
right, the commitments are very large.
They're over many years, and of course the revenue is growing quickly,
but it's still a large amount,
and so the way we think about that is we actually...
We actually tend to buy on the low side.
We buy relatively little compute for relatively low cost ahead of time.
And then if things do not as well relative to expectations,
we're well covered.
If things go really well relative to expectations,
then we have an opportunity
to buy additional compute on the spot market,
which so far has always been available
and which we believe will continue to be available.
That costs more, but we're buying it
in worlds where we're doing particularly well.
So you can think of it
a little bit like we're buying an insurance policy.
And, of course, when you buy an insurance policy,
you have to pay more in worlds where you do well,
where something doesn't go wrong.
So that's the general strategy we're taking.
And we're very confident that with that strategy,
we can both invest in R&D when we need to
and, therefore, capture the upside and invest.
And, you know, for periods of time where things don't go as well,
we're well covered and we're well insulated.
I think a lot of, if I made a chart of all the people in this room
who are buying tokens today,
probably, like, those numbers are going up like this.
And so a lot of us have learned very quickly
to take some of the expensive stuff.
You don't need expensive models.
You can use far cheaper models, cheaper tokens, do the calculations.
Part of that's becoming a commodity.
Where would that be wrong?
Yeah, yeah, a couple of things.
So, first point is that as we build greater models
on the frontier,
Every time we extend the frontier, it creates entirely new markets.
So I think people are used to a certain pattern
from early stage to mature stage of a company
or a market, right?
First, there are all these startups,
people are willing to pay a large amount, and then,
you know, the thing commoditizes
and you hear words like commoditization, Mo, is there a
cheap alternative?
That does happen to some extent within
one particular application of AI.
So you look at, for example, chatbots as one particular application.
That arc sort of has happened.
But I think the thing that's different about
this field is AI isn't just one application.
It isn't just one market.
You're on an exponential of cognition.
And as the exponential proceeds, new markets become possible.
In 2023, everyone was focused on chatbots.
But what Anthropic did is we looked at what
the models were capable of and we said, no,
we think there's going to be a big thing around coding.
The models are starting to get smart enough for coding.
And coding is going to be much bigger than chatbots.
And so we focused on the frontier,
not on all the issues around trying to contend for
the chatbot market or consolidate the chatbot market
or build moats around the chatbot market.
Now, coding is starting to get more mature.
I think there's still a long way to go in coding.
You know, we look at the amount of penetration across the Fortune 500.
There's still a lot left to do.
But even as coding is starting to mature,
I think the excitement is going to move to these new areas
which are going to be much larger than coding
in the same way that coding was much larger than chatbots.
So you look at things like scientific discovery, life sciences.
You know, we mentioned physics, physics and materials,
robotics, cybersecurity.
These are even more difficult challenges than vanilla coding.
And so we're always focused on the frontier.
A second point is that even within the markets
where there's need for non-frontier models,
where people say, oh, yeah,
we don't need the frontier models for this task
because the task reaches its limit in terms of difficulty,
as happened to chatbots.
Even within that, we have the capability to take our large models
And train smaller models.
that are better than the smaller models that anyone else can produce.
So, because we have these things called compute multipliers,
we make our large models very efficient,
and that allows us to also make
our small models very efficient as well.
You look at a model like Haiku 5.5.
We've been able to...
Offer Haiku 3.5 for 10 cents per million token
of input and 50 cents per million tokens of output.
That's, I think it's something
like 40 times cheaper than Fable.
No, it's 100, I think, 100 times cheaper.
Thank you very much.
80 times.
And that huge differential comes because
we're able to make these models so efficient.
And the fact that we're able to make them
so efficient comes from the compute multipliers.
And the fact that we're able to make
these compute multipliers, you look at...
You look at the other models that are in the ecosystem,
and Haiku actually can Pareto
dominate some of these.
We're actually able to make cheap models.
It's really a misnomer that there are expensive models
that are good, and there are cheap
models from other providers.
Once we put our mind to it,
we're able to make cheap models that are just as efficient
as models from anyone else.
Okay, so you answered most of my next question, but just now you just.
Dream a little bit about, can it cure cancers and diseases,
fusion, quantum, all these things
which could be unbelievable breakthroughs for mankind.
Can it do that, help do that down the road?
Yeah, so we've again seen this pattern in any given area.
So we look at an area like mathematics,
and I've seen, as we kind of climb the exponential of the technology,
seen the same pattern everywhere over and over again.
So in something like 2023, models couldn't even do high school math.
If you think back to 2023, the conventional wisdom,
On things like chatbots was they're good at talking to you,
but they're not good at math.
They're not good at logic.
And in 2024, models got to the point where they could
do high school math reasonably well.
In 2025, they started solving unsolved problems in mathematics,
minor unsolved problems in mathematics.
You'd see one or two here and there,
and people would say, you can't, you know,
oh yeah, you know, that must have
been in the model's training data, or it just got lucky,
or that problem was particularly suited for being solved with AI.
Then you get to the point where you're seeing
a hundred open problems being solved at once.
And then you start to see major open problems being solved
that are among the hardest mathematicians have solved,
that are things where you could win the Fields Medal for it.
And so, having seen this pattern many times,
when we're starting to see the early stages of this
in new areas like biology and robotics,
you see the same pattern.
The experts are very skeptical, right?
The pharma CEOs are skeptical.
They've seen so many technologies in the past
try to solve their problems,
and they've seen that their problems are fiendishly difficult.
Same with mathematics, same with coding, right?
There's a long history of people trying to solve coding
and there's a long history of people doing chatbots.
But AI has this tendency where because it's on an exponential,
it looks like it's not going to do anything
or it looks like there are blockers.
In life sciences, people say things like,
well, it's the clinical trials that are the blockers.
Well, it's the manufacturing that's the blockers.
Well, it's the FDA that's the blockers.
And what we are finding is
Little by little,
and then I think we'll be all at once within a few years,
each of these steps are being addressed by AI.
And so there's no way to be sure.
Again, for any given field, the skeptics could be right.
But I see an incredible potential for us
to solve biology in an absolutely incredible way.
Let's move on to some of the risk of this thing.
So cyber was one of our biggest risks before Mythos.
Before agents, and now,
and we have thousands of people working in cyber, literally, and
maybe tens of thousands trying to fix some
of the vulnerabilities that have been disclosed
because of the Mythos.
We were lucky to be part of Glasswing,
and agents, of course, now the persistent agents
are completely attacking almost every perimeter you have out there.
What should everyone be thinking about doing
to get ready for what's coming and to protect themselves
and our vendors and industries in general?
And for the people in the room, I think you know, but there
are a lot of industries who have no protection, but they are vital.
And so we all have to help one day
to get all these industries up to speed.
Yeah, so a few things. One, I would say, you know,
finding vulnerabilities is the first step, right?
Since Mythos came out, you know,
the thing we've worked on most is finding vulnerabilities.
But that's only the first step. And what we found is that,
you know, you can find 100,000 vulnerabilities, right?
Like our customers have found hundreds of thousands of vulnerabilities.
We found hundreds of thousands of vulnerabilities.
Then the limiting step becomes how
do you actually patch the vulnerabilities?
And so that's taken a little bit further along the exponential
because patching things is harder than finding the vulnerabilities.
And so increasingly, we're starting to offer services and cloud
is starting to become better at patching the vulnerabilities.
Because for a while, it was like, oh, we found all these things,
but basically we found all these holes
and you can't patch them fast enough, we can't patch them fast enough.
I think the third step after patching is writing code
that's more secure in the first place.
And so we're beginning to offer things that can do that.
And of course, simply coding with Claude,
as Claude gets better at coding, it also gets better.
We deliberately train it at being better
at writing secure code.
So that's number three.
And then number four, which I think hasn't really happened
to a great scale yet, but that I continue
to be very excited about is cyber attacks happen
in real time, right?
Like an attack happens over hours or minutes
or maybe even seconds.
And so having swarms of agents that sort
of defensively patrol what a company has,
a company's servers,
and are able to defend against attacks in real time,
this is something that I think has a lot of value.
And I think when we look six or 12 months from now,
more and more of it is going to be that
because swarms are going to engage in attack.
So, you know, we're going to need swarms in order to do the defense.
Okay, so they're going public, so the big question is why now,
but maybe a little bit also how you feel about it
because there are pluses and minuses.
Are you looking forward to it? Do you think it's going to make
your company better or a little more difficult to manage?
Yeah, I mean, you know,
I think there's a few reasons to go public right now.
I mean, I think just the biggest one,
it goes back to these compute bets, right,
where there's enormous opportunity
in the world where the economic value
and the opportunities around, you know,
work in biology, work in robotics,
work in cybersecurity, knowledge work in general,
there's enormous opportunity,
and we want to make sure that we invest enough
to make sure that we achieve those opportunities.
And so that buffer between the low compute world
and the high compute world,
just the more cash we have on hand,
the more buffer we have between those two things.
You know,
I would say that the second thing is we're
not super fussed on when exactly,
what month, or what day, or what market conditions we go public into.
You know, when we started this process,
and I'd never done anything like this process before,
you know, the company went from nothing
to where we are now in basically six years,
so I asked a bunch of people for advice, and the most common advice,
or the one that resonated with me the most,
it was all versions of something like
never let your company be worth
a single dollar more than it's really worth,
Which I think is very similar to.
A model that we have within Anthropic,
which is under-promise and over-deliver.
This is the way Anthropic communicates, right?
We don't talk about all the exciting things we're going to do
in terms of safety, in terms of model capabilities.
We don't vague post about models ahead of time.
We basically build the model,
we make sure it's good, we release the model.
We build the safety system, we make sure it's good,
we release the safety system.
And so I think of this event in the same way,
that we want to under-promise and over-deliver.
Okay. You also announced a public benefit fund,
which a lot of us are probably not really familiar with.
So I'd love you to describe it,
why you did it, what's your vision for it?
Yeah, so we decided to take 5% of the company
and put it in what we call a public benefit fund.
This is in addition to pledges that the co-founders have made
to donate 80% of their wealth.
And another program, which we've
been doing since the beginning of the company,
which is that when we make offers to employees,
there's a donation matching program,
where if they donate a particular percentage of their shares to
charity or set them aside,
the company matches those with additional shares.
And
And so putting these three together, you know, we have this idea that.
a
AI is an incredibly powerful technology, right?
you
We look at the economic value that it's already generated
for this company, for the industry
very
as a whole, and then we think that is,
you know, our hope, we can't be sure, our hope
is that that is small compared to these future opportunities.
much.
And of course, many great things will come from it.
You know, I hope we'll cure cancer.
I hope we'll cure Alzheimer's.
I hope we'll build cheaper energy and more abundant,
you know, better materials.
More material abundance for everyone, but there really is a worry
that because so much of that new wealth is coming from
You know this one singular technology
Represented by a few companies that we could have a world where there's
enormous growth, but at the same time there's concentration of wealth
And so we want to do everything we can to counter that concentration
of wealth and the public benefit fund is part of that
We're still working out, again,
Anthropic tends to under promise and over deliver.
We're not going to go out and say,
we're going to solve this problem and that problem and
that problem.
We're trying to figure out what the best problems
to solve are with the public benefit fund.
But you know, you can imagine areas that we're worried about,
making sure that the labor
transition with AI goes well.
Things like biosecurity,
making sure that all these great things will happen with biology
Like cyber, like any other technology, it can be misused.
So making sure that those misuses don't happen,
and we have good defenses against them.
Things like that.
So this is the last question.
You go fast forward like 15 years.
Look back.
What do you hope actually happened,
and what do you hope actually didn't happen?
And then also, anything else you want
to say to the audience out here that maybe we missed?
Yeah, a few things, you know, I think the most important thing I want
to make sure happen is that the technology is built in the right way,
you know, I've talked about the risks of the technology
and the risks of it going wrong, I think those are extremely serious,
ranging from misuse of the technology for bio or cyber to the possible
economic disruptions to, of course, you know, losing control of agents.
Those aren't marketing,
we're really serious about those risks and we have put effort
into addressing those risks since the beginning of the company.
So I think the most important thing is that we set
an example for the whole field of how
to address those risks.
Those risks certainly don't happen that Anthropic,
but I think that's not enough.
We need to make sure that the rest of the AI industry
and the customers of the AI industry
and the suppliers of the AI industry.
That we set an example for all of those players
so that everyone else behaves responsibly as well.
That is what the company has been trying to do since the beginning.
So making sure that the downsides are addressed,
I see that as the number one most important thing.
The number two thing, of course,
is making sure that we achieve all the benefits.
And again, we're just at the beginning
of what can be done in biology and medicine.
There's a lot of skepticism from pharma,
from early stage biotech, from academic biologists.
We can't know ahead of time, maybe the skeptics are right,
but my hope is that we prove the
skeptics are wrong and every disease you can think of,
heart disease, Alzheimer's, cancer,
we think of those the way we think of bubonic plague or smallpox today,
that they're relics
of the past.
And I think we can have a much more beautiful world,
I think we can have a world in which
All of these problems are addressed.
It sounds starry-eyed.
It sounds crazy.
I really do believe it.
I really do believe it can be done.
And, you know, I don't know, five years,
10 years, 15 years, I don't know exactly.
But we're going to try to do it as fast as we can.
So before I thank you and all the other people
and coming for coming here, I'm going to leave the last word to Mary.
May all of your words be true.
I think we're all so hopeful that you
and your management team do exactly what you have said.
And very importantly, the line that Dario said is one
of the very important lines in that prospectus in the S1
where he says that the goal is to under-promise and to over-deliver,
and we sure hope you do that.
Thank you for everything that you've done.
And please join us with the management team
and all of these earliest investors
to tell you about what they thought
when they began investing in the company.
Enjoy.
